Yale Cancer Center Study Shows Aspirin & Intermediate Dose Anticoagulation Improves Survival for Hospitalized COVID-19 Patients
February 04, 2021
February 04, 2021
NEW HAVEN, Connecticut, Feb. 4 (TNSJou) -- Yale School of Medicine issued the following news:
According to a new study led by Yale Cancer Center, researchers discovered aspirin and intermediate dose anticoagulation can improve mortality rates for patients hospitalized with COVID-19. The study was published in in the American Journal of Hematology.
Thrombotic complications occur at high rates in hospitalized patients with COVID-19, yet the impact of intensive antithrombo . . .
According to a new study led by Yale Cancer Center, researchers discovered aspirin and intermediate dose anticoagulation can improve mortality rates for patients hospitalized with COVID-19. The study was published in in the American Journal of Hematology.
Thrombotic complications occur at high rates in hospitalized patients with COVID-19, yet the impact of intensive antithrombo . . .